21Sep 2023
Survival with chronic myeloid leukaemia after failing milestones

Survival with chronic myeloid leukaemia after failing milestones

Therapy options for Chronic Myeloid Leukemia (CML) patients who fail response milestones remain a topic of debate due to associated risks. A study of 1342 newly diagnosed CML patients examined long-term survival after reaching or missing response milestones. Results revealed that patients failing milestones (e.g., >10% BCR::ABL1IS at 6 months) had a 10% lower survival rate than responders, suggesting a need to revise these milestones. Age didn't significantly impact survival, but it influenced hazard ratios and CML-specific survival. Switching to alternative therapies did not alter the main findings. This study provides insights for individualized treatment decisions.

  • #oncology

Like

Save

Share